Genetics of bronchopulmonary dysplasia: An update

被引:10
|
作者
Lavoie, Pascal M. [1 ,2 ,5 ]
Rayment, Jonathan H. [2 ,3 ,4 ]
机构
[1] Univ British Columbia, Dept Pediat, Div Neonatol, Vancouver, BC, Canada
[2] BC Childrens Hosp, Res Inst, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Pediat, Div Resp Med, Vancouver, BC, Canada
[4] BC Childrens Hosp, Div Resp Med, Vancouver, BC, Canada
[5] British Columbia Childrens Res Inst, Translat Res Bldg,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada
关键词
Bronchopulmonary dysplasia; Genetics; Infant; Premature; Gene expression; Surfactant proteins; ATP-binding cassette; Sub-family A; Member; 3; SURFACTANT PROTEIN-B; NEONATAL RESPIRATORY-DISTRESS; NECROSIS-FACTOR-ALPHA; ANGIOTENSIN-CONVERTING ENZYME; INTERSTITIAL LUNG-DISEASE; COPY NUMBER VARIATION; ABCA3; MUTATIONS; PRETERM INFANTS; RISK-FACTORS; PULMONARY SURFACTANT;
D O I
10.1016/j.semperi.2023.151811
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Bronchopulmonary dysplasia (BPD) is a multi-factorial disease that results from multiple clinical factors, including lung immaturity, mechanical ventilation, oxidative stress, pulmonary congestion due to increasing cardiac blood shunting, nutritional and immunological factors. Twin studies have indicated that susceptibility to BPD can be strongly inherited in some settings. Studies have reported associations between common genetic variants and BPD in preterm infants. Recent genomic studies have highlighted a potential role for molecular pathways involved in inflammation and lung development in affected infants. Rare mutations in genes encoding the lipid transporter ATP-binding cassette, sub-family A, member 3 (ABCA3 gene) which is involved in surfactant synthesis in alveolar type II cells, as well as surfactant protein B (SFTPB) and C (SFTPC) can also result in severe form of neonatal-onset interstitial lung diseases and may also potentially affect the course of BPD. This chapter summarizes the current state of knowledge on the genetics of BPD.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Bronchopulmonary dysplasia (chronic lung disease of infancy) - An update for the pediatrician
    Nievas, FF
    Chernick, V
    CLINICAL PEDIATRICS, 2002, 41 (02) : 77 - 85
  • [22] Bronchopulmonary Dysplasia and chronic Lung Disease - Update on Prevention and Treatment
    Prenzel, F.
    ALLERGOLOGIE, 2016, 39 (05) : 220 - 221
  • [23] Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches
    Michael, Zoe
    Spyropoulos, Fotios
    Ghanta, Sailaja
    Christou, Helen
    CLINICAL MEDICINE INSIGHTS-PEDIATRICS, 2018, 12
  • [24] An update on the diagnosis and management of bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension
    Berkelhamer, Sara K.
    Mestan, Karen K.
    Steinhorn, Robin
    SEMINARS IN PERINATOLOGY, 2018, 42 (07) : 432 - 443
  • [25] An update on the post-NICU discharge management Check for of bronchopulmonary dysplasia
    Bhandari, Anita
    Panitch, Howard
    SEMINARS IN PERINATOLOGY, 2018, 42 (07) : 471 - 477
  • [26] Commentary: Expert Opinion to "Imaging Bronchopulmonary Dysplasia-A Multimodality Update"
    Wielpuetz, Mark O.
    FRONTIERS IN MEDICINE, 2021, 8
  • [27] When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia
    Lena Holzfurtner
    Tayyab Shahzad
    Ying Dong
    Lisa Rekers
    Ariane Selting
    Birte Staude
    Tina Lauer
    Annesuse Schmidt
    Stefano Rivetti
    Klaus-Peter Zimmer
    Judith Behnke
    Saverio Bellusci
    Harald Ehrhardt
    Molecular and Cellular Pediatrics, 9
  • [28] Bronchopulmonary Dysplasia
    Deakins, Kathleen M.
    RESPIRATORY CARE, 2009, 54 (09) : 1252 - 1262
  • [29] Bronchopulmonary dysplasia
    Schmidt, Alexander R.
    Ramamoorthy, Chandra
    PEDIATRIC ANESTHESIA, 2022, 32 (02) : 174 - 180
  • [30] Bronchopulmonary dysplasia
    Clement, A
    REVUE DES MALADIES RESPIRATOIRES, 1996, 13 (03) : 243 - 249